Results 51 to 60 of about 1,696 (185)
Indian Journal of Critical Care Medicine, 2015 Sir, We read the case report “use of a novel hemadsorption device for cytokine removal as adjuvant therapy in a patient with septic shock with multi-organ dysfunction: A case study” by Basu et al.[1] with great interest. We would like to share our experiences with a similar patient in our Intensive Care Unit and discuss some of the intriguing ...
Pattnaik, Saroj Kumar +1 more
openaire +3 more sources
Opportunities, controversies, and challenges of extracorporeal hemoadsorption with CytoSorb during ECMO [PDF]
Artificial Organs, 2021 AbstractExtracorporeal membrane oxygenation (ECMO) is frequently used in many centers around the globe for various indications. However, prognosis is often poor even with all supportive therapies, and in many cases, clinical deterioration is associated with inflammation.
Napp, L. Christian +4 more
openaire +3 more sources
Journal of Translational Medicine, 2017 Background Ex-vivo normothermic perfusion strategies are a promising new instrument in organ transplantation. The perfusion conditions are designed to be protective however the artificial environment can induce a local inflammatory response.
Sarah A. Hosgood +4 more
doaj +1 more source
BMJ Open, 2021 Introduction Sepsis and septic shock have mortality rates between 20% and 50%. In sepsis, the immune response becomes dysregulated, which leads to an imbalance between proinflammatory and anti-inflammatory mediators.
Péter Hegyi +13 more
doaj +1 more source
Severe Vasoplegic Syndrome Treated with Angiotensin II and Hemoadsorption Therapy after Cardiac Surgery. [PDF]
Catheter Cardiovasc IntervABSTRACT Vasoplegic syndrome (VS) is a common complication after cardiac surgery with cardiopulmonary bypass (CPB). The main pathophysiology mechanism of VS includes a systemic inflammatory response syndrome due to surgical trauma, release of pro‐inflammatory mediators caused by blood contact with foreign surfaces of heart‐lung machine (pump and tubing)
Lucchelli M +3 more
europepmc +2 more sources
Hemoperfusion with CytoSorb® in Critically Ill COVID-19 Patients [PDF]
Blood Purification, 2021 <b><i>Introduction:</i></b> Systematic inflammatory response occurred in some critically ill patients with COVID-19. Cytokine reduction by hemadsorption is a mechanism of treatment. However, whether CytoSorb hemoperfusion works for critically ill COVID-19 patients remains unknown.
Jin-Yu, Peng +5 more
openaire +2 more sources
Journal of Cardiovascular Development and Disease, 2023 A considerable number of infective endocarditis (IE) patients require cardiac surgery with an increased risk for postoperative sepsis. Intraoperative hemoadsorption may diminish the risk of postoperative hyperinflammation with potential economic ...
Cristina Rao +7 more
doaj +1 more source
, 2022 Reflete-se sobre uma inovação tecnológica denominada CytoSorb® e que é um dispositivo relativamente novo no mercado. O objetivo geral deste trabalho é dar a conhecer o CytoSorb® e as vantagens da sua utilização. O CytoSorb® traz um variado leque benefícios nas mais diversas áreas da Medicina, no entanto, optou-se por abordar dois aspetos relacionados ...
Marmeleira, Sofia +3 more
openaire +1 more source
Veterinary Medicine: Research and Reports, 2023 John Meagher, Jeanette Hendricks, Adam Eatroff Advanced Critical Care Emergency and Specialty Services, Culver City, CA, USACorrespondence: John Meagher, Advanced Critical Care Emergency and Specialty Services, 9599 Jefferson Blvd, Culver City, CA, 90232,
Meagher J, Hendricks J, Eatroff A
doaj
Trials, 2022 Background Liver cirrhosis is a major healthcare problem and the mortality rate is high. During recent years, systemic inflammation has been recognized as a major driver of hepatic decompensation and progression of liver cirrhosis to acute-on-chronic ...
Asieb Sekandarzad +6 more
doaj +1 more source